Antiviral Drug Market

Antiviral Drug Market Overview

According to the latest study by FMI, antiviral drug packaging market is expected to grow at a significant rate owing to the rising concerns regarding numerous viral infection. Significant increase in demand for much safer packaging solution especially in the pharmaceutical sector is propelling the sales of materials used for packaging.

Moreover, constant demand for antiviral drugs to cure various viral infections is projected to bolster the demand and sales while growing a CAGR of around ~7% over the forecast period.

What is Driving Demand for Antiviral Drug Packaging?

Over the past decade there has been a rise in infection related diseases. Also COVID-19 pandemic has shown urgency in making packaging solutions safer and efficient in order to reduce the spread of virus.

Antiviral drugs needs to be protected from contamination of various microbial organisms in order to protect the health of consumers. Also consumers today demand an overall safety through packaging to prevent themselves from the exposure of virus. Hence constant demand for more efficient packaging solutions will propel its sales in the long run.

Moreover, over past half decade there has been a surge in sales of antiviral drugs. This can be attributed to the rising cases of various viral infectious diseases along with innovation in the drug development. This surge in sales of drugs has called for more efficient and durable packaging of products thus increasing the sales of materials used for packaging in the long run.

COVID-19 to give Major Boost in Sales of Antiviral Drug Packaging

Past two years have been of high growth for drug manufacturers and pharmaceutical companies with sales of products seeing unprecedented maturity. Sales of antiviral and lifesaving drugs such as   FabiFlu and remdisivir has seen substantial rise in demand and sales during pandemic.

Owing to these factors drug packaging manufacturers geared up their production to meet the need of end use segment. This trend is projected to increase the sales of drugs and related packaging materials in the long run.

Moreover, there is a constant demand from consumers for new packaging materials that is able to exhibit antiviral properties. Concerns regarding ability of viruses to survive on the surface has compelled packaging material manufacturers to innovate and develop new materials in accordance to the need of present times.

Thus above mentioned factors coupled with constant demand for antiviral drugs is projected to bolster the sales of packaging materials for antiviral drugs.

North America Antiviral Drug Packaging Market Outlook

North America is poised to show strong growth in the sales of packaging material for antiviral drugs mainly attributed to the well-established pharmaceutical sector in the region.

Additionally, approval of various antiviral drugs by government agencies such as Antiviral Veklury manufactured by prominent drug manufacturer Gilead has provided an uptick rise in demand and sales of respective drug.

Moreover, rise in number of cases and rapid spread of virus has propelled the sales of antiviral drugs which in turn has spearheaded the demand of packaging materials.

Such notable key trends in the region is projected to help increase the sales of packaging material used by antiviral drug manufacturers over the projected forecast period.

Ismail Sutaria

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Asia Pacific Antiviral Drug Packaging Market Outlook

Asia Pacific is expected to be the most lucrative market for antiviral drugs and its packaging materials owing to increasing health infrastructure and high government spending. Also drug development in the region has picked up pace with production and innovation taking place.

For instance, it has been projected that in next five years healthcare spending in Asia Pacific is poised to grow by ~40% expanding at the rate 2x than world average.

Moreover, COVID-19 pandemic has propelled the overall sales of various antiviral drugs in the region and has come out to be the most promising region for drug sales. These factors have called for efficient packaging materials to be produced thus driving its demand and sales in the long run.

Who are the Key Manufacturers and Suppliers of Antiviral Drug Packaging?

Some of the key prominent players in the industry includes

• Avery Dennison Corporation
• E.I. du Pont de Nemours
• CCL Industries Inc
• BioCote
• Avient
• Mondi
• Biomaster
• BASF
• Lonza
• Takex Labo Co. Ltd
• Berry
• Lageen Tubes.

Above mentioned key players have mainly relied on organic growth strategies such as innovation and product launches.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments.

The report also maps the qualitative impact of various market factors on market segments and geographies.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Sign-Up

Key Segments

By Material:

• Rigid plastic
• Pumps
• Flexible blister foils

By Application:

• Packaging
• Tubing

By End Use:

• Pharmaceuticals
• Healthcare

By Region:

• North America
• Latin America
• Europe
• East Asia
• South Asia & Oceania
• Middle East & Africa